List view / Grid view
Abbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA® (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa (HS).
19 March 2012 | By Takeda Pharmaceutical Company Limited
Results presented at 76th Annual Scientific Meeting of the Japanese Circulation Society in Fukuoka...
18 March 2012 | By Pfizer
Experts on ageing highlight importance of health as driver of economic growth...
16 March 2012 | By Novartis
Potential first pharmacological treatment for symptomatic vitreomacular adhesion...
16 March 2012 | By Sanofi
Sanofi and Pluromed Inc. have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc...
15 March 2012 | By GlaxoSmithKline
Agreement reached to divest brands in Europe to Omega Pharma for €470m (£391m)...
14 March 2012 | By HACH LANGE
Modern pharmaceutical injectable drug production is heavily regulated...
13 March 2012 | By Roche
The 2nd request seeks additional information regarding Roche’s microarray business...
13 March 2012 | By kdm communications limited
Laboratory scale chemists offered educational workshops and seminars...
13 March 2012 | By AstraZeneca
AstraZeneca will vigorously defend its legal rights...
12 March 2012 | By Pfizer
Data from a Phase 3 study of Prevnar 13® met all study endpoints...
12 March 2012 | By Pfizer
Biocon and Pfizer have announced the conclusion of their alliance...
9 March 2012 | By GlaxoSmithKline
New scheme to offer 40 annual apprenticeships in manufacturing, R&D and IT...
9 March 2012 | By AstraZeneca
The FDA denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labelling...
8 March 2012 | By Abbott
U.S. FDA clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System...
